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Abstract 
Gardnerella vaginalis is the most frequent microorganism found in bacterial vaginosis (BV), 
while Escherichia coli and Enterococcus faecalis are amongst the most frequent pathogens 
found in urinary tract infections (UTIs). This study aimed to evaluate possible interactions 
between UTIs pathogens and G. vaginalis using an in vitro dual-species biofilm model. Our 
results showed that dual-species biofilms reached significantly higher bacterial concentration 
than mono-species biofilms. Moreover, visualization of dual-populations species in the 
biofilms, using the epifluorescence microscopy, revealed that all of the urogenital pathogens 
co-existed with G. vaginalis. In conclusion, our work demonstrates that uropathogens can 
incorporate into mature BV biofilms. 
 
Main text 
The human vaginal microbiota plays an important role in the maintenance of the woman’s 
health. When this community is disrupted, bacterial vaginosis (BV) may occur (Schwebke et 
al., 2014). It has been described that as BV progresses, an highly structured polymicrobial 
biofilm develops in the vaginal epithelium primarily consisting of G. vaginalis and a variety of 
other bacteria (Verstraelen & Swidsinski, 2013). BV can lead to complications in 
pregnancies, causing premature rupture of the membranes, premature birth, or the death of 
the fetus or newborn (Eschenbach et al., 1988). Furthermore, urogenital diseases can also 
result from BV, especially urinary tract infections (UTIs) (Harmanli et al., 2000, Sharami et 
al., 2007). Association between BV and UTIs probably begins with an increase in the pH of 
the vagina because of the reduction of vaginal lactobacilli-that are able to produce lactate 
and hydrogen peroxide (Sumati & Saritha, 2009). Consequently, uropathogenic 
microorganisms can emerge from the gut (Whiteside et al., 2015) and come into contact with 
the vaginal microenvironment but little is known about what happens thereafter. It has been 
proposed that uropathogens can either bypass the microflora or successfully enter the 
vaginal biofilms, survive, and continue their ascension into the bladder (Reid G & Habash, 
1999). Although anatomical proximity allows easy transfer of bacteria from the vagina to 
urinary tract and vice versa (Pedraza-Aviles et al., 2001, Sharami et al., 2007), to date only a 
 
 
 
 
few investigators have been examined the role of the uropathogens in BV. Importantly, a 
recent study (Amatya et al., 2013) reported that in a population of 135 BV-positive women, 
75% also had UTIs. The leading uropathogen isolated from women with UTIs is Escherichia 
coli (Soto et al., 2007), and this organism has also been known to form biofilms of the 
urogenital tract (Hancock et al., 2010, McMillan et al., 2011). Similarly, Enterococcus faecalis 
have also been associated with UTIs and is known to form biofilms (Hola et al., 2010).  
This study aimed to evaluate the interactions between a G. vaginalis isolate from a BV-
positive patient (UM241, NCBI accession number: KP996683) (Castro et al., 2015) and three 
E. coli (UM056, NCBI: KT614048; UM062, NCBI: KT614049; and UM066Ec, NCBI: 
KT614050) or three E. faecalis (UM035, NCBI: KT614045; UM066Ef, NCBI: KT614046; and 
UM067, NCBI: KT614047) isolates using a mono- or dual-species biofilm model described 
previously by Machado et al. (2013a). The bacteria used were isolated and identified as 
described previously (Alves et al. 2014). Briefly, dual-species biofilms where initiated by 
inoculating a 107 CFU/mL bacterial suspension of G. vaginalis [in brain heart infusion (BHI, 
Liofilchem, Roseto degli Abruzzi, Italy) supplemented with 2% (w/w) gelatin (Oxoid Ltd., 
Basingstoke, Hampshire, United Kingdom), 0.5% (w/w) yeast extract (Liofilchem) and 0.1% 
(w/w) starch (Panreac, Barcelona, Spain)] in 24-well tissue culture plate (Orange Scientific, 
Braine L’Alleud, Belgium) for 24 h, at 37ºC under 10% CO2. After 24 h, the planktonic cells 
were removed and fresh media was added to each well. Then, 107 CFU/mL of each 
uropathogen isolate was inoculated with the pre-formed G. vaginalis biofilm, for another 24 
h. One control was performed where no secondary pathogen was added. Other mono-
species biofilms controls were performed by inoculating equivalent bacterial suspension of 
each uropathogen in 24 well-plate for 24 h. To quantify the total cells of a mono- and dual-
species biofilm we used the method suggested by Freitas et al. (2014). In brief, the total cells 
were quantified using a Neubauer chamber coupled with Olympus BX51 epifluorescence 
microscope equipped with a CCD camera (DP72; Olympus). Cell suspensions were stained 
with 4’-6-Diamidino-2-phenylindole (DAPI, 2.5 μg/mL). DAPI staining was detected in a 
specific filter, BP 365-370, FT 400, LP 421 present in the microscope. Next, we 
discriminated the bacterial population of biofilm by using the Peptide Nucleic Acid (PNA) 
Fluorescence in situ hybridization method as previously described Machado et al. (2013b). 
Briefly, after fixing the biofilm, a PNA probe specific for G. vaginalis (Gard 162) was added to 
each well of epoxy coated microscope glass slides (Thermo Fisher Scientific, Lenexa, KS, 
USA). An additional staining step was done at the end of the hybridization procedure, 
covering each glass slide with DAPI. Microscopic visualization was performed using filters 
capable of detecting the PNA probe (BP 530-550, FT 570, LP 591 sensitive to the Alexa 
Fluor 594 molecule attached to the Gard162 probe) and DAPI (as described above). Finally, 
biomass quantification was performed by crystal violet (CV) method as described by Peeters 
et al. (2008). In brief, after the fixation step, biofilms were stained with 100 µL of crystal violet 
(CV) solution 0.5% (v/v) (Acros Organics, New Jersey, USA) for 20 min. Each well was 
washed two times with 200 µL of phosphate buffered saline, and then the CV was removed 
by adding 150 µL of glacial acetic acid (v/v) (Thermo Fisher Scientifc) to each well. The 
plates were placed in agitation for a few minutes and finally the optical density (OD) was 
measured at 590 nm. To determine the extent of the coaggregation between G. vaginalis 
and uropathogens we used an experimental model suggested by Reid et al. (1990). In brief, 
500 µL of G. vaginalis (107 CFU/mL) was combined with 500 µL of each uropathogen (107 
CFU/mL) in 24-well plates. Then, bacteria were incubated for 4 h, at 37ºC, in 10% CO2. The 
aggregates were visualized using an inverted light microscope (Leica DMI 3000B) and the 
score was evaluated as following: 0, no aggregation; 1, small aggregates comprising small 
visible clusters of bacteria; 2, aggregates comprising larger numbers of bacteria, settling to 
the center of the well; 3, macroscopically visible clumps comprising larger groups of bacteria 
which settle to the center of the well; 4, maximum score allocated to describe a large, 
macroscopically visible clump in the center of the well. Auto-aggregation was assessed for 
each bacterial isolate. All experiments were performed in triplicate with technical replicates. 
The data were analyzed using the t-test, with the statistical software package SPSS 17.0 
(SPSS Inc. Chicago, IL). P-values of less than 0.05 were considered significant. 
 
 
 
 
 
Our results showed that all tested uropathogens isolates had a significant ability to increase 
the total number of cells within a pre-formed G. vaginalis biofilm (Fig. 1A). Remarkably, we 
showed that these dual-species biofilms were composed majority by uropathogens (Fig. 1B), 
suggesting that the tested species can live in close proximity with each other, to some 
extent. This was first confirmed by the coaggregation experiments, being E. faecalis the 
species with the highest ability to interact with G. vaginalis by coaggregation (Fig. 1C). Direct 
epifluorescence microscopy further confirmed this, with clusters of uropathogens in close 
contact with G. vaginalis (Fig. 1D).  
 
 
 
Fig. 1A | Biofilm formation profiles for each species on mono- and dual-species biofilms. Total cells 
counts by DAPI for mono- (controls) and dual-species biofilms. *P < 0.05 when compared the dual-
species biofilms to each mono-species biofilm (uropathogen control). ** P < 0.05 when compared the 
24h G. vaginalis biofilm (control) to dual-species biofilm. *** P < 0.05 when compared the 48h G. 
vaginalis biofilm (control) to dual-species biofilm. 
 
Fig. 1B | Biofilm formation profiles for each species on mono- and dual-species biofilms. Total 
percentage of cells detected by PNA FISH for 48h biofilms. *P < 0.05 when compared the dual-species 
biofilms to each mono-species biofilm (uropathogen control). 
 
 
 
 
 
Interestingly, despite the increase in bacterial concentration, dual-species biofilm total 
biomass was not significantly augmented after added the uropathogens in a pre-formed G. 
vaginalis biofilm (when compared with mono-species biofilms of G. vaginalis), with exception 
to 2 E. faecalis isolates (UM035 and UM067). This is probably due to the relative lower 
biomass formation by both E. coli and E. faecalis mono-species biofilms, as compared to G. 
vaginalis, in our tested conditions (Fig. 1E). Similarly, Almeida et al. (2011) reported that the 
total biomass profiles in dual-species biofilms tended to be more similar to mono-species 
biofilm. 
 
 
 
Fig. 1C| Coaggregation score of mono- and dual-bacterial species, the score was evaluated on a 0 to 4 
scale. 
 
Fig. 1D | Epifluorescence image showing E. faecalis UM035 mixed with G. vaginalis, E. faecalis is 
shown blue and G. vaginalis in red. 
 
Taken in consideration all the above data, we showed that both E. coli and E. faecalis had 
the ability to incorporate into a pre-formed G. vaginalis biofilm with increased cell 
concentrations. These findings may be explained due to virulence factors of uropathogens, 
namely in the coaggregation process. Importantly, Reid & Sobel (1987) showed that 
uropathogens have ability to adhere to each other (autoaggregation) and possibly to other 
microorganisms (coaggregation). E. coli produces antigen 43 that favours the interbacterial 
interactions (Danese et al., 2000). Regarding E. faecalis, this uropathogen produce an 
aggregation substance, pheromone-inducible surface protein, encoded by agg gene that 
promotes aggregation during bacterial conjunction (Lopez-Salas et al., 2013). 
 
 
 
 
 
Fig. 1E | Biofilm thickness of mono- (controls) and dual-species biofilm determined by staining with 
crystal violet.  *P < 0.05 when compared the dual-species biofilms to each mono-species biofilm 
(uropathogen control). ** P < 0.05 when compared the 24h G. vaginalis biofilm (control) to dual-species 
biofilm. *** P < 0.05 when compared the 48h G. vaginalis biofilm (control) to dual-species biofilm. 
Although little is known about the underlying bacterial interactions between uropathogens 
and G. vaginalis, some studies reported that this association could lead an increase of the 
BV or UTIs- associated complications (Hooton et al., 1989, Hillebrand et al., 2002, Soto et 
al., 2007, Lata et al., 2010). In 1989, Hooton et al. reported that complications resulting from 
the use of diaphragms were higher in women with BV and UTIs. Later, some studies 
revealed that the incidence of poor pregnancy outcome was higher BV with UTIs (Hillebrand 
et al., 2002, Lata et al., 2010). Particularly, studies have been reported that premature 
rupture of the membranes can also be associated with UTIs (Soto et al., 2007). On the other 
side, the incorporation of uropathogens in G. vaginalis mediated biofilms provides a 
protective niche for a further potential UTI infection. Interestingly, Swidsinski et al. (2014) 
showed that little clusters of G. vaginalis can also embed in masses of other uropathogens in 
a woman with UTI. 
 
In conclusion, our novel observations revealed, for the first time, that uropathogens can 
associate in BV biofilm. Due to the complications associated with BV and UTIs in pregnant 
women, it would be important that antenatal patients should be screened for the presence 
of BV and UTIs. A future direction of this study will be examine gene expression in G. 
vaginalis and uropathogens, to identify biofilm genes, and examine metabolic, adhesion and 
coaggregation process that maintain the multi-species biofilms in order to find an effective 
treatment in co-occurrence of BV and UTIs. 
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